Skip to main navigation Skip to search Skip to main content

Immunocompetent Preclinical Mouse Models of Brain Cancer

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Brain cancer represents a critical public health issue with thousands of newly diagnosed patients per year in Europe and the United States facing a dismal prognosis. The tumor immune microenvironment (TIME) has recently emerged as a key player promoting brain tumor growth and shaping responses to therapy. Consequently, new strategies have been developed to target the immune component of brain cancers and foster ant-tumoral immune responses, although they have only proven effective in a subset of patients. Therefore, it is of utmost importance to understand the dynamic biology of the TIME upon therapeutic intervention. Here, I describe different immunocompetent preclinical mouse models of primary and metastatic brain cancer, which allow a comprehensive exploration of the role of the immune system in tumor progression and response to therapy.

Original languageEnglish
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Chapter12
Pages165-177
Number of pages13
Volume2959
DOIs
Publication statusPublished - 1 Oct 2025

Publication series

NameMethods in molecular biology (Clifton, N.J.)
ISSN (Print)1064-3745

Keywords

  • Brain cancer
  • Brain metastasis
  • Glioblastoma
  • Immunocompetent
  • Preclinical models
  • Tumor microenvironment
  • Brain Neoplasms/immunology
  • Humans
  • Animals
  • Tumor Microenvironment/immunology
  • Mice
  • Immunocompetence
  • Disease Models, Animal

Fingerprint

Dive into the research topics of 'Immunocompetent Preclinical Mouse Models of Brain Cancer'. Together they form a unique fingerprint.

Cite this